At 5.7% CAGR, North America Non-Invasive Ventilation Masks Market is Projected to be Worth US$ 1,412.14 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the North America non-invasive ventilation masks market was valued at US$ 902.92 million in 2023 and is expected to reach US$ 1,412.14 million by 2031, registering a CAGR of 5.7% from 2023 to 2031. Rising technological advancements and growing inclination towards home healthcare are among the critical factors attributed to drive the North America non-invasive ventilation masks market growth.

Technological innovations are enhancing patient experience, improving design, and driving functionality. Patient compatibility is due to technological advancements, such as cushioning effects that allow patients to modify the shape of their nasal bridges. As a result, a customized fit ensures ideal contact and distributes pressure applied to the skin, thereby significantly reducing the likelihood of skin breakdown and associated complications. For instance, NIV masks are frequently needed by patients in hospital and intensive care unit settings to support their respiratory needs. Although these masks are essential for patient care, they can occasionally cause skin irritations and discomfort, especially in the area surrounding the nasal bridge. One of the leading medical device manufacturers, Sleepnet, created the ground-breaking AIR°gel technology to solve these issues. Every Sleepnet mask uses AIR°gel, which lessens skin breakdown and gives patients more comfort and protection. Notable NIV mask products that use these advancements include VariFit and Evora. These developments in NIV masks meet the patients' requirements and improve effectiveness, comfort, and overall results while wearing the masks.

On the contrary, side effects associated with NIV masks hamper the growth of North America non-invasive ventilation masks market.

By product, the North America non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held 59.8% share of North America non-invasive ventilation masks market share in 2023, amassing US$ 539.93 million. It is projected to garner US$ 825.46 million by 2031 to register 5.4% CAGR during 2023–2031.

In terms of application, the North America non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held 55.1% share of North America non-invasive ventilation masks market share in 2023, amassing US$ 497.39 million. It is projected to garner US$ 794.39 million by 2031 to register 6.0% CAGR during 2023–2031.

Based on end user, the North America non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held 50.1% share of North America non-invasive ventilation masks market share in 2023, amassing US$ 452.24 million. It is projected to garner US$ 718.02 million by 2031 to register 5.9% CAGR during 2023–2031.

Based on country, the North America non-invasive ventilation masks market is categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 82.3% share of North America non-invasive ventilation masks market in 2023. It was assessed at US$ 742.65 million in 2023 and is likely to hit US$ 1,178.56 million by 2031, registering a CAGR of 5.9% during 2023–2031.

Key players operating in the cosmetic preservatives market are Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD., among others.

• In May 2022: Air Liquide Healthcare launched ALNEST N1 Silent mask. Alnest N1 Silent and Alnest N1 are reusable nasal masks with calibrated exhalation orifices (vented) for adult patients (weighing more than 30 kg) undergoing non-invasive positive pressure ventilation therapy (NPPV) like CPAP or BiPAP.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com